Log in
Enquire now
‌

Tacalyx

Developer of cancer therapeutics targeting tumor associated carbohydrate antigens (TACAs)

OverviewStructured DataIssuesContributors

Contents

tacalyx.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Biomedical engineering
Biomedical engineering
Health technology
Health technology
Healthcare
Healthcare
Cancer
Cancer
Life science
Life science
Biotechnology
Biotechnology
Location
Germany
Germany
CEO
‌
Jean Engela
Pitchbook URL
pitchbook.com/profiles...277883-02
Number of Employees (Ranges)
1 – 10
Investors
Eurazeo
Eurazeo
Thuja Capital
Thuja Capital
Coparion
Coparion
Kurma Partners
Kurma Partners
IDInvest Partners
IDInvest Partners
High-Tech Gründerfonds
High-Tech Gründerfonds
Boehringer Ingelheim Venture Fund
Boehringer Ingelheim Venture Fund
Creathor Ventures
Creathor Ventures
Founded Date
2019
Total Funding Amount (USD)
28,300,000
15,300,000
Latest Funding Round Date
September 25, 2019
April 29, 2026
Latest Funding Type
Seed
Seed
Country
Germany
Germany
Headquarters
Berlin
Berlin

Other attributes

Company Operating Status
Active
Latest Funding Round Amount (USD)
13,000,000
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Tacalyx

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Pricing
  • Become an Editor
  • Enterprise

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.